5-(Trifluoromethyl)benzo[d]isoxazol-3-amine

Catalog No.: 
ACCDAI367
CAS No.: 
868271-14-1
Molecular Formula: 
C8H5F3N2O
Molecular Weight: 
202.13
5-(Trifluoromethyl)benzo[d]isoxazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$118.00In stockIn stock
1g95%$420.00In stockIn stock
5g95%$1890.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Trifluoromethyl)benzo[d]isoxazol-3-amine
IUPAC Name5-(trifluoromethyl)benzo[d]isoxazol-3-amine
MDL No.MFCD11847114
Molecular FormulaC8H5F3N2O
Molecular Weight202.13
SMILESNC1=NOC2=CC=C(C(F)(F)F)C=C12
InChI KeyLSKOZQNIAMSAIB-UHFFFAOYSA-N
Synonym5-(trifluoromethyl)benzo[d]isoxazol-3-amine;5-TrifluoroMethyl-benzo[d]isoxazol-3-ylaMine;5-(trifluoromethyl)-1,2-benzoxazol-3-amine;1,2-Benzisoxazol-3-amine, 5-(trifluoromethyl)-;3-Amino-5-(trifluoromethyl)benzisoxazole
CAS No.868271-14-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCDAI367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCDAI367 route product structure diagram
    ACCDAI367868271-14-1In Stock
Inquiry

2. ACCDAI367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCDAI367 route product structure diagram
    ACCDAI367868271-14-1In Stock
Inquiry

3. ACCDAI367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCDAI367 route product structure diagram
    ACCDAI367868271-14-1In Stock
Inquiry

Comments (0)